Compare MCRB & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCRB | PRPL |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.7M | 76.9M |
| IPO Year | 2015 | 2015 |
| Metric | MCRB | PRPL |
|---|---|---|
| Price | $7.79 | $0.51 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $14.00 | $0.65 |
| AVG Volume (30 Days) | 50.9K | ★ 391.6K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 152.75 |
| EPS | N/A | ★ N/A |
| Revenue | $789,000.00 | ★ $468,725,000.00 |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | N/A | $6.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.56 | $0.47 |
| 52 Week High | $29.98 | $1.26 |
| Indicator | MCRB | PRPL |
|---|---|---|
| Relative Strength Index (RSI) | 43.53 | 36.00 |
| Support Level | $6.56 | N/A |
| Resistance Level | $9.53 | $0.72 |
| Average True Range (ATR) | 0.64 | 0.04 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 48.04 | 19.90 |
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.